Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,278 public trials 1,201 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)

NCT04375904

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Beacon Hospital Dublin, Ireland

St Luke's Radiation Oncology Network (SLRON) at St Luke's Hospital and St James's Hospital Dublin, Ireland

View Trial Details

Recruiting

Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer

NCT05384873

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Fondazione IRCCS Policlinico San Matteo Pavia, Italy

View Trial Details

Recruiting

Multiomics Tumor Evolution Model of NSCLC

NCT05352035

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details

Recruiting

Integrin αvβ6-targeted PET in Malignant Tumors

NCT05835570

Conditions: Breast Cancer, Metastatic, Breast Diseases, Breast Neoplasms, +19 more
Locations: Zhongnan Hospital of Wuhan University Wuhan, Hubei, China

View Trial Details

Recruiting

A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China

NCT06718972

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations: Guangdong Sanjiu Brain Hospital Guangzhou, Guangdong, China

the First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

NCT06046495

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of California-Davis Sacramento, California, United States

Research Site Louisville, Kentucky, United States

Nebraska Cancer Specialists Omaha, Nebraska, United States

Research Site New York, United States

View Trial Details

Recruiting

Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3)

NCT06926790

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: First Affiliated Hospital of Guangzhou Medical University Guangzhou, China

View Trial Details

Recruiting

Prehabilitation for Patients Undergoing Lung Cancer Surgery

NCT06716437

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The University of Melbourne, Department of Physiotherapy Parkville, Victoria, Australia

View Trial Details

Recruiting

Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC

NCT06939127

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, China

View Trial Details

Recruiting

A Study of DM001 in Patients With Advanced Solid Tumors

NCT06475937

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +12 more
Locations: Sarah Cannon Research Institute (SCRI) Nashville, Tennessee, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

Icon Cancer Centre South Brisbane South Brisbane, Queensland, Australia

Tasman Oncology Research Southport, Queensland, Australia

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions